[Clinicopathological features and prognostic factors associated with long-term survival (≥5 years) in patients with clear cell renal cell carcinoma and venous tumor thrombus].
About 14% of kidney cancer patients with advanced vascular involvement survive long-term after surgery, establishing realistic expectations for this group.
OBJECTIVE: To characterize the clinicopathological features of long-term survivors among patients with clear cell renal cell carcinoma (ccRCC) and venous tumor thrombus (VTT) who underwent surgical treatment, and to expl... RESULTS: Long-term survival was achieved in 13.9% of 397 patients with ccRCC and VTT.
What the study was
- Study design
- Cohort study
- Population
- patients
- Sample size
- 55
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Why it surfaced
Score 6/10 [PROMISING_PRELIMINARY]: Cohort study (Journal Article) matched 'Novel therapeutics: immunotherapy, CAR-T'. Components — novelty:1/3, relevance:2/3, design:1/2, population:2/2. Confidence: high. Conservative scoring applied per v1.3 rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.